Ozempic & Vision Loss: Separating Fact from Fiction In this video, Dr. Kulmeet Kundlas examines recent claims linking Ozempic (Semaglutide), a popular diabetes and weight loss medication, to cases of vision loss. The episode explores the specifics of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and other eye complications potentially associated with Ozempic. Dr. Kundlas provides a balanced view on the current scientific evidence, emphasizing the rarity of these side effects compared to the significant benefits of the drug. Patients and doctors are advised on how to mitigate risks and when to seek medical advice. Stay informed and get a professional perspective on this important health issue.